Link_NN between_IN Genome_NP Packaging_NP and_CC Rate_NP of_IN Budding_NP for_IN Rous_NP Sarcoma_NP Virus_NP The_DT subcellular_JJ location_NN at_IN which_WDT genomic_JJ RNA_NP is_VBZ packaged_VBN by_IN Gag_NP proteins_NNS during_IN retrovirus_NN assembly_NN remains_VBZ unknown_JJ ._SENT Since_IN the_DT membrane-binding_NN (_( M_NP )_) domain_NN is_VBZ most_RBS critical_JJ for_IN targeting_VBG Gag_NP to_TO the_DT plasma_NN membrane_NN ,_, changes_NNS to_TO this_DT determinant_NN might_MD alter_VB the_DT path_NN taken_VBN through_IN the_DT cell_NN and_CC reduce_VB the_DT efficiency_NN of_IN genome_NN packaging_NN ._SENT In_IN this_DT report_NN ,_, a_DT Rous_NP sarcoma_NN virus_NN (_( RSV_NP )_) mutant_NN having_VBG two_CD acidic-to-basic_JJ substitutions_NNS in_IN the_DT M_NP domain_NN is_VBZ described_VBN ._SENT This_DT mutant_NN ,_, designated_VBN Super_NP M_NP ,_, produced_VBD particles_NNS much_RB faster_RBR than_IN the_DT wild_JJ type_NN ,_, but_CC the_DT mutant_JJ virions_NNS were_VBD noninfectious_JJ and_CC contained_VBD only_RB 1/10_CD the_DT amount_NN of_IN genomic_JJ RNA_NP found_VBD in_IN wild-type_NN particles_NNS ._SENT To_TO identify_VB the_DT cause(s)_NN of_IN these_DT defects_NNS ,_, we_PP considered_VBD data_NNS that_WDT suggest_VBP that_IN RSV_NP Gag_NP traffics_VBZ through_IN the_DT nucleus_NN to_TO package_VB the_DT viral_JJ genome_NN ._SENT Although_IN inhibition_NN of_IN the_DT CRM-1_JJ pathway_NN of_IN nuclear_JJ export_NN caused_VBD the_DT accumulation_NN of_IN wild-type_NP Gag_NP in_IN the_DT nucleus_NN ,_, nuclear_JJ accumulation_NN did_VBD not_RB occur_VB with_IN Super_NP M._NP The_DT importance_NN of_IN the_DT nucleocapsid_NN (_( NC_NP )_) domain_NN in_IN membrane_NN targeting_VBG was_VBD also_RB determined_VBN ,_, and_CC ,_, importantly_RB ,_, deletion_NN of_IN the_DT NC_NP sequence_NN prevented_VBD plasma_NN membrane_NN localization_NN by_IN wild-type_NP Gag_NP but_CC not_RB by_IN Super_NP M_NP Gag_NP ._SENT Based_VBN on_IN these_DT results_NNS ,_, we_PP reasoned_VBD that_IN the_DT enhanced_JJ membrane-targeting_NN properties_NNS of_IN Super_NP M_NP inhibit_VBP genome_NN packaging_NN ._SENT Consistent_JJ with_IN this_DT interpretation_NN ,_, substitutions_NNS that_WDT reestablished_VBD the_DT wild-type_NN number_NN of_IN basic_JJ and_CC acidic_JJ residues_NNS in_IN the_DT Super_NP M_NP Gag_NP M_NP domain_NN reduced_VBD the_DT budding_JJ efficiency_NN and_CC restored_VBN genome_NN packaging_NN and_CC infectivity_NN ._SENT Therefore_RB ,_, these_DT data_NNS suggest_VBP that_IN Gag_NP targeting_VBG and_CC genome_NN packaging_NN are_VBP normally_RB linked_VBN to_TO ensure_VB that_IN RSV_NP particles_NNS contain_VBP viral_JJ RNA_NP ._SENT Gag_NN polyproteins_NNS form_VBP retrovirus-like_JJ particles_NNS that_WDT bud_VBP from_IN the_DT plasma_NN membrane_NN ._SENT Gag_NN is_VBZ synthesized_VBN by_IN soluble_JJ ribosomes_NNS and_CC is_VBZ targeted_VBN to_TO the_DT site_NN of_IN budding_VBG by_IN the_DT membrane-binding_NN (_( M_NP )_) domain_NN located_VBN in_IN the_DT N-terminal_JJ region_NN ._SENT In_IN most_JJS retroviruses_NNS (_( e.g._FW ,_, human_JJ immunodeficiency_NN virus_NN type_NN 1_CD [_SYM HIV-1_NP ]_SYM )_) ,_, the_DT M_NP domain_NN contains_VBZ both_DT myristate_NN and_CC a_DT cluster_NN of_IN basic_JJ residues_NNS ,_, which_WDT form_VBP hydrophobic_JJ and_CC electrostatic_JJ interactions_NNS with_IN membrane_NN phospholipids_NNS ,_, respectively_RB ._SENT In_IN Rous_NP sarcoma_NN virus_NN (_( RSV_NP )_) ,_, an_DT avian_JJ retrovirus_NN ,_, the_DT M_NP domain_NN maps_NNS to_TO the_DT first_JJ 86_CD residues_NNS in_IN Gag_NP ._SENT Although_IN it_PP is_VBZ not_RB myristylated_JJ ,_, the_DT RSV_NP M_NP domain_NN contains_VBZ 11_CD basic_JJ residues_NNS ,_, and_CC according_VBG to_TO the_DT nuclear_JJ magnetic_JJ resonance_NN structure_NN of_IN the_DT M_NP domain_NN ,_, these_DT basic_JJ residues_NNS are_VBP present_JJ on_IN the_DT surface_NN of_IN the_DT molecule_NN ._SENT Because_IN substitutions_NNS of_IN two_CD or_CC more_JJR basic_JJ residues_NNS in_IN the_DT M_NP domain_NN prevent_VB targeting_VBG and_CC budding_VBG ,_, RSV_NP Gag_NP may_MD bind_VB to_TO the_DT plasma_NN membrane_NN by_IN forming_VBG electrostatic_JJ interactions_NNS with_IN acidic_JJ phospholipids_NNS ._SENT In_IN addition_NN to_TO budding_VBG ,_, Gag_NP is_VBZ responsible_JJ for_IN packaging_NN two_CD copies_NNS of_IN the_DT retroviral_JJ genome_NN ._SENT Efficient_JJ packaging_NN requires_VBZ the_DT presence_NN of_IN basic_JJ residues_NNS and_CC one_CD or_CC two_CD copies_NNS of_IN a_DT zinc_NN finger_NN motif_NN (_( Cys-X2-Cys-X2-His-X4-Cys_NP )_) in_IN the_DT nucleocapsid_NN (_( NC_NP )_) domain_NN of_IN Gag_NP ._SENT These_DT elements_NNS enable_VBP specific_JJ interactions_NNS between_IN Gag_NP and_CC the_DT packaging_NN signal_NN (_( Psi_NP )_) ,_, which_WDT is_VBZ located_VBN in_IN the_DT 5_CD '_POS end_NN of_IN the_DT viral_JJ RNA_NP (_( vRNA_NP )_) ._SENT Aside_RB from_IN the_DT interaction_NN between_IN NC_NP and_CC Psi_NP ,_, many_JJ aspects_NNS of_IN genome_NN packaging_NN remain_VBP unknown_JJ ._SENT Of_IN particular_JJ interest_NN is_VBZ the_DT subcellular_JJ location(s)_NN at_IN which_WDT Gag_NP first_RB binds_VBZ vRNA_NN ._SENT Recently_RB ,_, RNA_NP targeting_VBG motifs_NNS known_VBN as_IN A2_JJ response_NN elements_NNS have_VBP been_VBN identified_VBN in_IN the_DT genomes_NNS of_IN several_JJ retroviruses_NNS ._SENT In_IN addition_NN ,_, the_DT RNA-targeting_NP protein_NN Staufen_NP has_VBZ been_VBN implicated_VBN in_IN genome_NN packaging_NN by_IN HIV-1_NP Gag_NP ._SENT Although_IN the_DT functional_JJ significance_NN of_IN these_DT findings_NNS is_VBZ unclear_JJ ,_, these_DT data_NNS suggest_VBP that_IN RNA-targeting_NP proteins_NNS might_MD enhance_VB the_DT efficiency_NN of_IN genome_NN packaging_NN by_IN transporting_VBG vRNA_NN to_TO the_DT sites_NNS of_IN Gag_NP assembly_NN ._SENT Given_VBN the_DT importance_NN of_IN the_DT M_NP domain_NN in_IN Gag_NP targeting_VBG ,_, it_PP is_VBZ possible_JJ that_IN changes_NNS in_IN this_DT domain_NN would_MD alter_VB the_DT pathway_NN by_IN which_WDT Gag_NP trafficks_NNS through_IN the_DT cell_NN ,_, and_CC such_JJ changes_NNS might_MD also_RB affect_VB the_DT efficiency_NN of_IN genome_NN packaging_NN ._SENT There_EX is_VBZ evidence_NN for_IN this_DT possibility_NN from_IN RSV_NP ,_, where_WRB a_DT twofold_JJ reduction_NN in_IN the_DT efficiency_NN of_IN genome_NN packaging_NN is_VBZ caused_VBN by_IN adding_VBG the_DT myristylated_JJ ,_, nine-amino-acid_JJ Src_NP M_NP domain_NN to_TO the_DT N_NP terminus_NN of_IN Gag_NP ._SENT The_DT mutant_NN ,_, known_VBN as_IN Myr1E_NP ,_, is_VBZ also_RB noninfectious_JJ ,_, and_CC the_DT packaged_VBN vRNA_NN is_VBZ monomeric_JJ ._SENT Stimulated_VBN by_IN the_DT potential_JJ role_NN of_IN the_DT M_NP domain_NN in_IN genome_NN packaging_NN ,_, we_PP characterized_VBD an_DT RSV_NP mutant_NN with_IN two_CD substitutions_NNS ,_, E25K_NP and_CC E70K_NP ,_, in_IN the_DT M_NP domain_NN ._SENT Although_IN the_DT acidic-to-basic_JJ substitutions_NNS enhanced_VBD budding_VBG by_IN this_DT mutant_NN ,_, designated_VBN Super_NP M_NP ,_, the_DT extracellular_JJ particles_NNS were_VBD noninfectious_JJ and_CC contained_VBD only_RB 1/10_CD the_DT amount_NN of_IN vRNA_NN found_VBN in_IN wild-type_NN (_( WT_NP )_) particles_NNS ._SENT To_TO identify_VB the_DT cause(s)_NN of_IN these_DT defects_NNS ,_, we_PP considered_VBD recent_JJ data_NNS that_WDT suggest_VBP that_IN RSV_NP Gag_NP must_MD transit_VB the_DT nucleus_NN to_TO package_NN vRNA_NN ._SENT In_IN contrast_NN to_TO WT_NP ,_, Super_NP M_NP Gag_NP did_VBD not_RB accumulate_VB in_IN the_DT nucleus_NN when_WRB cells_NNS were_VBD treated_VBN with_IN leptomycin_NN B_NP (_( LMB_NP )_) ,_, an_DT inhibitor_NN of_IN nuclear_JJ export_NN ._SENT In_IN addition_NN ,_, the_DT importance_NN of_IN Gag-Gag_NP interactions_NNS in_IN RSV_NP targeting_VBG was_VBD tested_VBN by_IN deleting_VBG the_DT NC_NP domain_NN and_CC examining_VBG the_DT subcellular_JJ distribution_NN of_IN mutant_JJ and_CC WT_NP proteins_NNS ._SENT Interestingly_RB ,_, deletion_NN of_IN the_DT NC_NP sequences_NNS prevented_VBD WT_NP Gag_NP from_IN accumulating_VBG on_IN the_DT plasma_NN membrane_NN ,_, but_CC Super_NP M_NP Gag_NP targeting_VBG was_VBD unaffected_JJ ._SENT Together_RB ,_, these_DT results_NNS suggest_VBP that_IN the_DT Super_NP M_NP substitutions_NNS alter_VBP the_DT targeting_VBG properties_NNS of_IN RSV_NP Gag_NP ._SENT Because_IN the_DT altered_JJ targeting_VBG phenotypes_NNS of_IN Super_NP M_NP are_VBP likely_RB caused_VBN by_IN an_DT enhanced_JJ affinity_NN for_IN the_DT plasma_NN membrane_NN ,_, it_PP was_VBD possible_JJ that_IN packaging_NN and_CC infectivity_NN would_MD also_RB be_VB disrupted_VBN ._SENT To_TO test_VB this_DT possibility_NN ,_, additional_JJ substitutions_NNS that_WDT reestablished_VBD the_DT WT_NP number_NN of_IN basic_JJ and_CC acidic_JJ residues_NNS were_VBD introduced_VBN to_TO the_DT Super_NP M_NP Gag_NP domain_NN ,_, and_CC these_DT changes_NNS reduced_VBD the_DT budding_JJ rate_NN and_CC restored_VBN genome_NN packaging_NN and_CC infectivity_NN ._SENT Hence_RB ,_, these_DT observations_NNS suggest_VBP a_DT relationship_NN between_IN genome_NN packaging_NN and_CC membrane_NN targeting_VBG by_IN RSV_NP Gag_NP ._SENT Proviral_JJ expression_NN vectors_NNS and_CC mutagenesis_NN ._SENT |_SYM The_DT WT_NP gag_NN gene_NN used_VBN in_IN these_DT studies_NNS was_VBD obtained_VBN from_IN the_DT Prague_NP C_NP strain_NN of_IN RSV_NP ._SENT To_TO create_VB pRS.V8-EGFP_NN ,_, gag_NN was_VBD cloned_VBN via_IN the_DT unique_JJ SstI_NP and_CC HpaI_NP sites_NNS into_IN pRCAS-EGFP_NN ,_, a_DT proviral_JJ plasmid_NN that_WDT expresses_VBZ green_JJ fluorescent_JJ protein_NN (_( GFP_NP )_) from_IN the_DT nonessential_JJ v-src_NN region_NN of_IN the_DT genome_NN ._SENT The_DT substitutions_NNS present_JJ in_IN Super_NP M_NP Gag_NP and_CC the_DT charge-balanced_JJ mutant_JJ proviral_JJ plasmids_NNS were_VBD generated_VBN by_IN oligonucleotide-directed_JJ mutagenesis_NN using_VBG previously_RB described_VBN methods_NNS ._SENT The_DT sequences_NNS of_IN the_DT mutagenic_JJ oligonucleotides_NNS and_CC the_DT resulting_JJ substitutions_NNS (_( underlined_VBN )_) are_VBP as_RB follows_VBZ :_: for_IN Super_NP M_NP ,_, the_DT E25K_NP oligonucleotide_NN sequence_NN is_VBZ 5'-CTAAGAAGAAAATAGGGGCCATG_JJ and_CC the_DT E70K_NP oligonucleotide_NN sequence_NN is_VBZ 5'-GAAATCGGGAAAGTTAAAAACC_JJ ;_: for_IN K6,18E-Super_NP M_NP ,_, the_DT K6E_NP oligonucleotide_NN sequence_NN is_VBZ 5'-GCCGTCATAGAGGTGATTTCGTCC_JJ and_CC the_DT K18E_NP oligonucleotide_NN sequence_NN is_VBZ 5'-CTATTGCGGGGAAACTAGTCCTTC_JJ ;_: for_IN K13,18E-Super_NP M_NP ,_, the_DT K13E_NP oligonucleotide_NN sequence_NN is_VBZ 5'-GTCCGCGTGTGAAACCTATTG_JJ and_CC the_DT K18E_NP oligonucleotide_NN has_VBZ the_DT sequence_NN shown_VBN above_IN ._SENT Analysis_NN of_IN particle_NN release_NN ._SENT |_SYM Duplicate_NN cultures_NNS of_IN QT6_NP (_( quail_NN )_) cells_NNS were_VBD transfected_VBN with_IN mutant_JJ or_CC WT_NP proviral_JJ plasmids_NNS by_IN the_DT calcium_NN phosphate_NN method_NN ._SENT Both_DT cultures_NNS were_VBD labeled_VBN with_IN l-[35S]methionine_NN (_( 0.1_CD muCi/mul_NN ,_, >1,000_NP Ci/mmol_NP )_) in_IN methionine-free_JJ Dulbecco_NP 's_POS modified_JJ Eagle_NP medium_NN (_( DMEM_NP )_) at_IN 16_CD h_NN posttransfection_NN ._SENT One_PP set_VBD was_VBD labeled_VBN for_IN only_RB 5_CD min_NN ,_, while_IN the_DT other_JJ was_VBD labeled_VBN for_IN 2.5_CD h._NN After_IN the_DT 5-min_NN labeling_VBG ,_, the_DT media_NNS were_VBD discarded_VBN ,_, and_CC the_DT cells_NNS were_VBD lysed_VBN in_IN radioimmunoprecipitation_NN assay_NN buffer_NN ._SENT For_IN the_DT 2.5-h_JJ labeling_VBG ,_, media_NNS and_CC cell_NN lysate_NN fractions_NNS were_VBD prepared_VBN ._SENT After_IN proteins_NNS were_VBD immunoprecipitated_VBN with_IN antiserum_NN raised_VBN against_IN purified_VBN RSV_NP ,_, the_DT samples_NNS were_VBD denatured_VBN and_CC separated_VBN by_IN sodium_NN dodecyl_NN sulfate-polyacrylamide_NN gel_NN electrophoresis_NN (_( SDS-PAGE_NP )_) ._SENT The_DT amounts_NNS of_IN labeled_VBN Gag_NP in_IN the_DT lysates_NNS of_IN the_DT cells_NNS labeled_VBN for_IN 5_CD min_NN and_CC the_DT amounts_NNS of_IN capsid_NN (_( CA_NP )_) protein_NN released_VBN into_IN the_DT media_NNS after_IN the_DT 2.5-h_NN labeling_VBG were_VBD quantified_VBN by_IN phosphorimagery_NN ._SENT The_DT budding_JJ efficiency_NN was_VBD calculated_VBN by_IN dividing_VBG the_DT amount_NN of_IN CA_NP released_VBN after_IN 2.5_CD h_NN by_IN the_DT amount_NN of_IN Gag_NP in_IN the_DT 5-min_JJ lysate_NN ._SENT The_DT data_NNS are_VBP expressed_VBN as_IN percentages_NNS of_IN the_DT WT_NP efficiency_NN of_IN release_NN ,_, which_WDT was_VBD set_VBN to_TO 100_CD %_NN ._SENT Pulse-chase_NN analyses_NNS were_VBD performed_VBN by_IN transfecting_VBG identical_JJ cultures_NNS of_IN QT6_NP cells_NNS with_IN WT_NP or_CC mutant_JJ proviral_NN (_( pRS.V8-EGFP_NN )_) plasmids_NNS ._SENT After_IN 16_CD h_NN ,_, the_DT cells_NNS were_VBD washed_VBN and_CC labeled_VBN for_IN 10_CD min_NN with_IN l-[35S]methionine_NN (_( 0.1_CD muCi/mul_NN ,_, >1,000_NP Ci/mmol_NP )_) in_IN methionine-free_JJ DMEM_NP ._SENT At_IN the_DT end_NN of_IN the_DT pulse_NN (_( time_NN zero_CD )_) ,_, one_CD culture_NN from_IN each_DT set_NN was_VBD placed_VBN on_IN ice_NN ,_, and_CC media_NNS and_CC cell_NN lysates_NNS were_VBD prepared_VBN with_IN radioimmunoprecipitation_NN assay_NN buffer_NN ._SENT For_IN the_DT remaining_VBG cultures_NNS ,_, the_DT labeling_VBG media_NNS were_VBD removed_VBN and_CC serum-free_JJ DMEM_NN containing_VBG an_DT excess_NN of_IN unlabeled_JJ methionine_NN was_VBD added_VBN ._SENT At_IN various_JJ times_NNS ,_, one_CD culture_NN from_IN each_DT set_NN was_VBD placed_VBN on_IN ice_NN ,_, and_CC media_NNS and_CC cell_NN lysates_NNS were_VBD prepared_VBN ._SENT After_IN full-length_JJ Gag_NP and_CC the_DT products_NNS of_IN Gag_NP proteolysis_NN were_VBD immunoprecipitated_VBN ,_, the_DT labeled_VBN proteins_NNS were_VBD detected_VBN and_CC quantified_VBN by_IN phosphorimagery_NN ._SENT To_TO determine_VB the_DT rate_NN of_IN Gag_NP disappearance_NN from_IN the_DT cell_NN ,_, the_DT amount_NN present_NN at_IN each_DT time_NN point_NN was_VBD divided_VBN by_IN the_DT amount_NN detected_VBD immediately_RB after_IN the_DT pulse_NN ._SENT To_TO determine_VB the_DT rate_NN of_IN Gag_NP accumulation_NN in_IN the_DT medium_NN ,_, the_DT amount_NN of_IN CA_NP present_NN at_IN each_DT time_NN point_NN was_VBD quantified_VBN ,_, and_CC this_DT number_NN was_VBD multiplied_VBN by_IN the_DT ratio_NN of_IN the_DT number_NN of_IN methionines_NNS in_IN full-length_JJ Gag_NP to_TO the_DT number_NN in_IN CA_NP (_( correction_NN factor_NN =_SYM 3_CD )_) ._SENT The_DT extrapolated_VBN value_NN was_VBD then_RB normalized_VBN by_IN the_DT amount_NN of_IN Gag_NP detected_VBD in_IN the_DT cell_NN lysates_VBZ immediately_RB after_IN the_DT pulse_NN ._SENT Infectivity_NN assays_NNS ._SENT |_SYM QT6_NP cells_NNS were_VBD transfected_VBN with_IN mutant_JJ or_CC WT_NP proviral_JJ DNA_NN ._SENT After_IN transfection_NN for_IN 16_CD h_NN ,_, the_DT cells_NNS were_VBD washed_VBN and_CC fresh_JJ media_NNS were_VBD added_VBN ._SENT Virus-containing_NP media_NNS were_VBD collected_VBN 48_CD h_NN later_RBR ,_, and_CC the_DT cellular_JJ debris_NN was_VBD pelleted_VBN by_IN centrifugation_NN for_IN 10_CD min_NN at_IN 2,000_CD x_SYM g._FW The_DT cell-free_JJ supernatants_NNS were_VBD transferred_VBN to_TO new_JJ tubes_NNS ,_, and_CC reverse_JJ transcriptase_NN (_( RT_NP )_) assays_NNS were_VBD performed_VBN to_TO determine_VB the_DT concentration_NN of_IN virus_NN ._SENT Turkey_NP embryo_NN fibroblasts_NNS (_( TEFs_NP )_) were_VBD then_RB inoculated_VBN with_IN equal_JJ numbers_NNS of_IN particles_NNS ._SENT After_IN 24_CD h_NN ,_, the_DT media_NNS were_VBD changed_VBN ,_, and_CC the_DT cells_NNS were_VBD passaged_VBN 1:3_CD every_DT 3_CD to_TO 4_CD days_NNS so_IN that_DT infectivity_NN could_MD be_VB determined_VBN at_IN days_NNS 3_CD ,_, 7_CD ,_, and_CC 14_CD postinfection_NN ._SENT To_TO measure_VB infectivity_NN ,_, the_DT cultures_NNS were_VBD trypsinized_VBN and_CC stored_VBN on_IN ice_NN ._SENT Approximately_RB 10,000_CD cells_NNS were_VBD then_RB examined_VBN for_IN the_DT presence_NN of_IN GFP_NP fluorescence_NN with_IN a_DT FACScan_NP (_( BD_NP Biosciences_NP )_) ._SENT As_IN mentioned_VBN above_JJ ,_, infected_JJ cells_NNS expressed_VBD GFP_NP from_IN the_DT nonessential_JJ v-src_NN region_NN of_IN the_DT viral_JJ genome_NN ._SENT Hence_RB ,_, the_DT percentage_NN of_IN infected_JJ cells_NNS was_VBD determined_VBN by_IN dividing_VBG the_DT number_NN of_IN green_JJ fluorescent_JJ cells_NNS by_IN the_DT total_JJ number_NN examined_VBD ._SENT To_TO determine_VB whether_IN infectivity_NN by_IN K6,18E-Super_NP M_NP or_CC K13,18E-Super_NP M_NP resulted_VBD from_IN unintended_JJ suppressor_NN mutations_NNS ,_, virus-containing_NN media_NNS were_VBD collected_VBN from_IN the_DT TEFs_NP at_IN 2_CD weeks_NNS postinfection_NN ,_, the_DT cellular_JJ debris_NN was_VBD removed_VBN by_IN centrifugation_NN (_( 10_CD min_NN at_IN 2,000_CD x_NN g_NN )_) ,_, and_CC aliquots_NNS of_IN the_DT media_NNS were_VBD used_VBN to_TO determine_VB the_DT virus_NN concentrations_NNS by_IN RT_NP assay_NN ._SENT Equal_JJ numbers_NNS of_IN WT_NP and_CC mutant_JJ virus_NN were_VBD added_VBN to_TO fresh_JJ ,_, uninfected_JJ TEFs_NNS ,_, and_CC the_DT percentage_NN of_IN infected_JJ (_( GFP-fluorescent_JJ )_) cells_NNS was_VBD determined_VBN at_IN 1_CD week_NN postinfection_NN ._SENT At_IN this_DT time_NN point_NN ,_, the_DT number_NN of_IN cells_NNS infected_VBN with_IN the_DT charge-balanced_JJ viruses_NNS would_MD be_VB similar_JJ to_TO the_DT number_NN infected_VBN by_IN the_DT WT_NP if_IN the_DT mutant_JJ viruses_NNS had_VBD made_VBN additional_JJ ,_, compensatory_JJ changes_NNS (_( e.g._FW ,_, reversion_NN of_IN the_DT Super_NP M_NP substitutions_NNS )_) during_IN the_DT primary_JJ infection_NN ._SENT However_RB ,_, cultures_NNS inoculated_VBD with_IN the_DT charge-balanced_JJ mutants_NNS contained_VBD one-fourth_NN to_TO one-third_NN the_DT number_NN of_IN fluorescent_JJ cells_NNS found_VBN in_IN WT-infected_JJ cultures_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT Analysis_NN of_IN physical_JJ properties_NNS and_CC protein_NN composition_NN of_IN extracellular_JJ virus_NN ._SENT |_SYM For_IN electron_NN microscopy_NN ,_, QT6_NP cells_NNS were_VBD seeded_VBN on_IN 60-mm-diameter_JJ Permanox_NP dishes_NNS and_CC transfected_VBN with_IN WT_NP or_CC Super_NP M_NP proviral_JJ DNA_NN ._SENT After_IN 16_CD h_NN ,_, the_DT cultures_NNS were_VBD washed_VBN with_IN 0.1_CD M_NP sodium_NN cacodylate_NN (_( pH_NN 7.4_CD )_) and_CC fixed_VBN in_IN 4_CD %_NN paraformaldehyde-0.5_NN %_NN glutaraldehyde_NN for_IN 1_CD h_NN at_IN 4C_JJ ._SENT Fixed_VBN cells_NNS were_VBD then_RB incubated_VBN for_IN 30_CD min_NN with_IN 1_CD %_NN osmium_NN tetroxide_NN ,_, dehydrated_VBD ,_, and_CC embedded_VBN in_IN Epon_NP 812_CD ._SENT Thin_JJ sections_NNS were_VBD stained_VBN with_IN uranyl_NN acetate_NN and_CC lead_NN citrate_NN ,_, and_CC extracellular_JJ particles_NNS were_VBD detected_VBN by_IN electron_NN microscopy_NN ._SENT To_TO determine_VB the_DT density_NN of_IN Super_NP M_NP virus_NN ,_, particle-containing_VBG media_NNS were_VBD collected_VBN after_IN labeling_VBG transfected_JJ QT6_NP cells_NNS for_IN 2.5_CD h_NN with_IN [_SYM 35S]methionine_JJ ._SENT Media_NNS were_VBD then_RB centrifuged_VBN (_( 10_CD min_NN at_IN 2,000_CD x_NN g_NN )_) to_TO remove_VB cellular_JJ debris_NN and_CC layered_VBN onto_IN a_DT 10_CD to_TO 50_CD %_NN gradient_NN of_IN sucrose_NN suspended_VBN in_IN phosphate-buffered_JJ saline_NN (_( PBS_NP )_) ._SENT As_IN an_DT internal_JJ control_NN ,_, labeled_VBN particles_NNS produced_VBN by_IN pGag-GFP_NN were_VBD added_VBN to_TO the_DT same_JJ gradient_NN ._SENT The_DT samples_NNS were_VBD then_RB centrifuged_VBN at_IN 83,500_CD x_NN g_NN for_IN 16_CD h_NN at_IN 4C_JJ ._SENT Sixteen_CD fractions_NNS of_IN 0.7_CD ml_NN each_DT were_VBD collected_VBN from_IN the_DT bottom_NN of_IN the_DT gradient_NN ,_, and_CC the_DT labeled_VBN Gag_NP proteins_NNS were_VBD immunoprecipitated_VBN ,_, resolved_VBN by_IN SDS-PAGE_NP ,_, and_CC quantified_VBN by_IN phosphorimagery_NN ._SENT The_DT amount_NN of_IN WT_NP or_CC mutant_JJ protein_NN in_IN each_DT fraction_NN is_VBZ expressed_VBN as_IN a_DT percentage_NN of_IN the_DT total_NN detected_VBN in_IN the_DT entire_JJ gradient_NN ._SENT The_DT density_NN of_IN each_DT fraction_NN was_VBD determined_VBN by_IN examining_VBG a_DT 50-mul_NN aliquot_NN by_IN refractometry_NN ._SENT The_DT levels_NNS of_IN Env_NP and_CC Pol_NP incorporated_VBD into_IN Super_NP M_NP particles_NNS were_VBD examined_VBN by_IN Western_NP blotting_VBG ._SENT Particles_NNS were_VBD collected_VBN from_IN transfected_JJ QT6_NP cells_NNS ,_, and_CC RT_NP assays_NNS were_VBD performed_VBN using_VBG exogenous_JJ templates_NNS (_( poly[A_NN ]_SYM )_) and_CC primers_NNS (_( oligo[dT_NP ]_SYM )_) ._SENT Virus_NN samples_NNS corresponding_JJ to_TO equal_VB amounts_NNS of_IN RT_NP activity_NN were_VBD denatured_VBN ,_, and_CC the_DT proteins_NNS were_VBD resolved_VBN by_IN SDS-PAGE_NP and_CC blotted_VBN to_TO nitrocellulose_NN membranes_NNS ._SENT To_TO detect_VB the_DT amount_NN of_IN CA_NP in_IN each_DT sample_NN ,_, the_DT membranes_NNS were_VBD incubated_VBN with_IN rabbit_NN polyclonal_JJ antisera_NN specific_NN for_IN RSV_NP Gag_NP and_CC the_DT products_NNS of_IN Gag_NP proteolysis_NN (_( anti-Gag_NN )_) ._SENT To_TO detect_VB the_DT levels_NNS of_IN Env_NP incorporated_VBD ,_, membranes_NNS were_VBD incubated_VBN with_IN rabbit_NN antisera_NN raised_VBN against_IN the_DT TM_JJ subunit_NN of_IN RSV_NP Env_NP (_( anti-TM_NN )_) ._SENT Primary_JJ antibody_NN binding_NN was_VBD visualized_VBN by_IN enhanced_JJ chemiluminescence_NN after_IN incubation_NN of_IN the_DT membranes_NNS with_IN goat_NN anti-rabbit_NN antibodies_NNS conjugated_VBN to_TO horseradish_NN peroxidase_NN ._SENT Analysis_NN of_IN genome_NN packaging_NN ._SENT |_SYM QT6_NP cells_NNS were_VBD transfected_VBN with_IN mutant_JJ or_CC WT_NP proviral_JJ DNA_NN ._SENT After_IN 16_CD h_NN ,_, the_DT transfection_NN media_NNS were_VBD removed_VBN ,_, the_DT cells_NNS were_VBD washed_VBN ,_, and_CC fresh_JJ media_NNS were_VBD added_VBN ._SENT Forty-eight_NP hours_NNS later_RBR ,_, virus-containing_NN media_NNS were_VBD collected_VBN and_CC the_DT cellular_JJ debris_NN was_VBD removed_VBN as_IN described_VBN above_IN ._SENT To_TO concentrate_VB the_DT extracellular_JJ virus_NN ,_, the_DT cell-free_JJ media_NNS were_VBD centrifuged_VBN at_IN 126,000_CD x_NN g_NN for_IN 40_CD min_NN at_IN 4C_JJ over_IN a_DT solution_NN of_IN 20_CD %_NN sucrose_NN in_IN PBS_NP ._SENT The_DT virus_NN pellet_NN was_VBD then_RB resuspended_VBN in_IN PBS_NP ,_, and_CC a_DT portion_NN was_VBD used_VBN to_TO determine_VB the_DT concentration_NN of_IN virus_NN by_IN RT_NP assay_NN ._SENT Particle-associated_NP RNA_NP was_VBD then_RB prepared_VBN with_IN the_DT TRI_NP reagent_NN (_( Sigma_NP )_) according_VBG to_TO the_DT supplier_NN 's_POS protocol_NN and_CC linear_JJ acrylamide_NN (_( Ambion_NP ;_: 10_CD mug/ml_NN )_) as_IN a_DT coprecipitant_NN ._SENT After_IN resuspension_NN in_IN diethyl_JJ pyrocarbonate_JJ (DEPC)-treated_JJ water_NN ,_, RNA_NP sample_NN volumes_NNS corresponding_JJ to_TO equal_VB numbers_NNS of_IN particles_NNS were_VBD denatured_VBN and_CC blotted_VBN to_TO nylon_NN membranes_NNS with_IN a_DT slot_NN blot_NN apparatus_NN ._SENT The_DT amount_NN of_IN genomic_JJ RNA_NP packaged_VBN by_IN each_DT virus_NN was_VBD detected_VBN by_IN hybridization_NN with_IN 32P-labeled_JJ antisense_NN riboprobes_NNS specific_JJ for_IN the_DT gag_NN gene_NN ,_, as_RB previously_RB described_VBN ._SENT The_DT amounts_NNS of_IN labeled_VBN RNA_NP bound_VBN to_TO each_DT sample_NN were_VBD quantified_VBN by_IN phosphorimagery_NN ._SENT In_IN a_DT similar_JJ manner_NN ,_, the_DT steady-state_NN levels_NNS of_IN genomic_JJ RNA_NP present_NN in_IN both_DT WT_NP and_CC Super_NP M-producing_NP cells_NNS were_VBD examined_VBN ._SENT The_DT levels_NNS of_IN genome_NN packaging_NN by_IN the_DT WT_NP and_CC Super_NP M_NP were_VBD also_RB examined_VBN by_IN RNase_NP protection_NN assay_NN (_( RPA_NP )_) and_CC Northern_NP blotting_VBG (_( data_NNS not_RB shown_VBN )_) ._SENT For_IN the_DT Northern_JJ blot_NN analyses_NNS ,_, particle-associated_VBD RNA_NP was_VBD purified_VBN as_IN described_VBN above_IN ._SENT RNA_NP sample_NN volumes_NNS corresponding_JJ to_TO equal_VB numbers_NNS of_IN virus_NN were_VBD denatured_VBN ,_, resolved_VBN on_IN 2.2_CD M_NP formaldehyde-1_JJ %_NN agarose_NN gels_NNS in_IN MOPS_NP (_( morpholinepropanesulfonic_JJ acid_NN )_) electrophoresis_NN buffer_NN ,_, and_CC blotted_VBD to_TO nylon_NN membranes_NNS by_IN standard_JJ techniques_NNS ._SENT Hybridizations_NNS with_IN a_DT 32P-labeled_JJ gag-specific_JJ riboprobe_NN were_VBD performed_VBN as_IN described_VBN above_IN ._SENT For_IN analysis_NN by_IN RPA_NP ,_, RNA_NP from_IN equivalent_JJ numbers_NNS of_IN Super_NP M_NP and_CC WT_NP particles_NNS was_VBD denatured_VBN and_CC hybridized_VBN with_IN a_DT 32P-labeled_JJ antisense_NN gag_NN riboprobe_NN (_( 532_CD nucleotides_NNS [_SYM nt_NNS ]_SYM )_) and_CC the_DT RPA_NP III_NP kit_NN (_( Ambion_NP )_) ._SENT Protected_JJ fragments_NNS (_( 502_CD nt_NNS )_) were_VBD separated_VBN by_IN electrophoresis_NN on_IN 5_CD %_NN acrylamide-8_JJ M_NP urea_NN gels_NNS and_CC quantified_VBN by_IN phosphorimagery_NN ._SENT To_TO determine_VB whether_IN Super_NP M_NP contained_VBD vRNA_NN dimers_NNS ,_, QT6_NP cells_NNS were_VBD transfected_VBN with_IN WT_NP or_CC mutant_JJ proviral_JJ DNA_NN and_CC the_DT extracellular_JJ particles_NNS were_VBD collected_VBN from_IN the_DT media_NNS by_IN ultracentrifugation_NN ._SENT RNA_NP from_IN equivalent_JJ numbers_NNS of_IN particles_NNS was_VBD purified_VBN and_CC resolved_VBN on_IN agarose_JJ gels_NNS under_IN native_JJ conditions_NNS as_IN described_VBN by_IN Fu_NP and_CC Rein_NP ._SENT After_IN electrophoresis_NN ,_, the_DT RNA_NP was_VBD denatured_VBN by_IN incubating_VBG the_DT gel_NN in_IN 6_CD %_NN formaldehyde_NN for_IN 30_CD min_NN at_IN 65C_JJ ._SENT After_IN several_JJ rinses_NNS in_IN DEPC-treated_JJ water_NN ,_, the_DT gel_NN was_VBD soaked_VBN in_IN 20x_NP SSC_NP (_( 1x_NP SSC_NP is_VBZ 0.15_CD M_NP NaCl_NP plus_CC 0.15_CD M_NP sodium_NN citrate_NN )_) ,_, and_CC the_DT RNA_NP was_VBD blotted_VBN to_TO nylon_NN membranes_NNS ._SENT Blotted_VBN RNA_NP was_VBD hybridized_VBN with_IN the_DT 32P-labeled_JJ gag_NN antisense_NN riboprobe_NN and_CC visualized_VBN by_IN autoradiography_NN (_( data_NNS not_RB shown_VBN )_) ._SENT Packaging_NN of_IN heterologous_JJ ,_, Psi-containing_NP RNA_NP ._SENT |_SYM The_DT 160-nt_JJ RSV_NP minimal_JJ packaging_NN sequence_NN ,_, MPsi_NP ,_, was_VBD defined_VBN by_IN Banks_NPS et_FW al._FW ._SENT To_TO create_VB pCMV.MPsi.gfp_NN ,_, we_PP used_VBD PCR_NP to_TO amplify_VB the_DT DNA_NN sequence_NN between_IN nt_JJ 156_CD and_CC 315_CD ,_, which_WDT encodes_VBZ MPsi_NP in_IN the_DT RSV_NP Prague_NP C_NP proviral_JJ plasmid_NN pATV-8_NN ._SENT The_DT sequences_NNS of_IN the_DT primers_NNS used_VBN for_IN PCR_NP were_VBD as_RB follows_VBZ :_: sense_NN ,_, 5'-AATAGATCTGATCCTGCCCTCATCC_NP ;_: antisense_NN ,_, 5'-TTAAGATCTGCGGCCGCCGTCTTCCAACG_NP ._SENT These_DT primers_NNS created_VBD BglII_NP sites_NNS (_( underlined_VBN )_) that_WDT flank_VBP the_DT MPsi_NP sequence_NN ,_, so_IN the_DT PCR_NP product_NN was_VBD digested_VBN and_CC inserted_VBN into_IN the_DT BglII_NP site_NN (_( nt_NN 610_CD )_) of_IN pEGFP-N2_NN (_( Clontech_NP )_) ,_, which_WDT expresses_VBZ GFP_NP from_IN the_DT cytomegalovirus_NN immediate-early_JJ promoter_NN ._SENT Positive_JJ clones_NNS containing_VBG a_DT single_JJ insert_NN in_IN the_DT proper_JJ orientation_NN were_VBD identified_VBN by_IN restriction_NN digestion_NN and_CC confirmed_VBD by_IN DNA_NP sequencing_NP ._SENT To_TO create_VB the_DT WT_NP gag-only_JJ expression_NN vector_NN ,_, the_DT Prague_NP C_NP gag_NN sequences_NNS from_IN the_DT proviral_JJ plasmid_NN pRC.V8_NN were_VBD isolated_VBN by_IN digestion_NN with_IN SstI_NP and_CC HpaI_NP ._SENT This_DT fragment_NN was_VBD inserted_VBN into_IN pEGFP-N2_NN after_IN the_DT gfp_NN sequences_NNS were_VBD removed_VBN by_IN digestion_NN with_IN SstI_NP and_CC NotI_NP ._SENT In_IN this_DT case_NN ,_, the_DT NotI_NP end_NN of_IN the_DT vector_NN DNA_NN was_VBD treated_VBN with_IN the_DT Klenow_NP fragment_NN of_IN E._NP coli_NNS DNA_NN polymerase_NN I_PP for_IN ligation_NN to_TO the_DT blunt_JJ HpaI_NP end_NN of_IN the_DT gag_NN fragment_NN ._SENT The_DT resulting_VBG plasmid_NN ,_, designated_VBN pCMV.GagPR_NN ,_, was_VBD transfected_VBN into_IN QT6_NP cells_NNS and_CC found_VBD to_TO synthesize_VB full-length_JJ Gag_NP proteins_NNS that_WDT were_VBD released_VBN into_IN the_DT medium_NN and_CC processed_VBN by_IN protease_NN (_( PR_NP )_) (_( data_NNS not_RB shown_VBN )_) ._SENT To_TO create_VB pCMV.Super_NP M.GagPR_NP ,_, the_DT SstI/BspEI_NP fragment_NN (_( 453_CD bp_NN )_) encoding_VBG the_DT Super_NP M_NP changes_NNS was_VBD exchanged_VBN with_IN the_DT corresponding_JJ WT_NP sequences_NNS in_IN pCMV.GagPR_NN and_CC the_DT resulting_VBG clones_NNS were_VBD screened_VBN by_IN DNA_NP sequencing_NP ._SENT The_DT abilities_NNS of_IN WT_NP and_CC Super_NP M_NP Gag_NP to_TO package_VB heterologous_JJ mRNA_NN were_VBD determined_VBN as_RB follows_VBZ ._SENT First_RB ,_, both_DT pCMV.MPsi.gfp_NN and_CC pEGFP-N2_NN ,_, designated_VBN MPsi(-).gfp_NP ,_, were_VBD cotransfected_VBN into_IN QT6_NP cells_NNS with_IN either_CC the_DT WT_NP or_CC Super_NP M_NP Gag_NP expression_NN vector_NN ._SENT All_DT plasmids_NNS were_VBD transfected_VBN at_IN equimolar_JJ amounts_NNS ,_, and_CC the_DT total_JJ amount_NN of_IN DNA_NN per_IN transfection_NN was_VBD 15_CD mug/35-mm-diameter_NN plate_NN ._SENT After_IN 12_CD h_NN ,_, the_DT transfection_NN media_NNS were_VBD removed_VBN ,_, and_CC the_DT monolayers_NNS were_VBD washed_VBN ._SENT The_DT cultures_NNS were_VBD then_RB trace_NN labeled_VBN with_IN [_SYM 35S]methionine_JJ (_( 0.1_CD muCi/mul_NN ,_, >1,000_NP Ci/mmol_NP )_) in_IN complete_JJ DMEM_NP containing_VBG 1_CD %_NN fetal_JJ bovine_JJ serum_NN ._SENT After_IN approximately_RB 20_CD h_NN of_IN labeling_VBG ,_, the_DT media_NNS were_VBD collected_VBN ,_, the_DT cellular_JJ debris_NN was_VBD removed_VBN by_IN low-speed_NN centrifugation_NN ,_, and_CC a_DT portion_NN of_IN each_DT supernatant_JJ was_VBD used_VBN to_TO determine_VB the_DT concentrations_NNS of_IN radiolabeled_JJ particles_NNS by_IN immunoprecipitation_NN ,_, SDS-PAGE_NP ,_, and_CC phosphorimager_NN analyses_NNS ._SENT Particles_NNS were_VBD then_RB pelleted_VBN from_IN the_DT remaining_VBG media_NNS ,_, and_CC the_DT particle-associated_JJ RNA_NP was_VBD purified_VBN with_IN the_DT TRI_NP reagent_NN (_( Sigma_NP )_) and_CC linear_JJ acrylamide_NN as_IN a_DT coprecipitant_NN ._SENT The_DT cell-associated_JJ RNA_NP was_VBD also_RB purified_VBN from_IN the_DT monolayers_NNS in_IN a_DT similar_JJ manner_NN ._SENT Upon_IN resuspension_NN of_IN the_DT RNA_NP in_IN DEPC-treated_NP water_NN ,_, equal_JJ volumes_NNS were_VBD mixed_VBN with_IN a_DT 32P-labeled_JJ antisense_NN riboprobe_NN (_( 306_CD nt_NNS )_) specific_JJ for_IN the_DT 5_CD '_POS ends_NNS of_IN MPsi.gfp_NP and_CC MPsi(-).gfp_NP mRNA_NP ._SENT After_IN hybridization_NN for_IN 16_CD h_NN at_IN 42C_NP ,_, RNase_NP digestions_NNS were_VBD performed_VBN with_IN the_DT RPA_NP III_NP kit_NN (_( Ambion_NP )_) ._SENT Protected_JJ fragments_NNS were_VBD resolved_VBN on_IN 4_CD %_NN acrylamide-8_JJ M_NP urea_NN gels_NNS and_CC quantified_VBN by_IN phosphorimagery_NN ._SENT Because_IN the_DT labeled_VBN riboprobe_NN contained_VBD both_DT MPsi_NP and_CC gfp_NN sequences_NNS ,_, the_DT presence_NN of_IN the_DT MPsi.gfp_NP mRNA_NN yielded_VBD a_DT protected_VBN band_NN of_IN 269_CD nt_NNS ,_, whereas_IN MPsi(-).gfp_NP mRNA_NP yielded_VBD a_DT protected_VBN band_NN of_IN 204_CD nt_NNS ._SENT To_TO calculate_VB the_DT packaging_NN efficiency_NN for_IN each_DT RNA_NP species_NN ,_, the_DT amount_NN detected_VBN in_IN the_DT medium_NN was_VBD divided_VBN by_IN the_DT steady-state_NN level_NN detected_VBN in_IN the_DT cell_NN ._SENT This_DT value_NN was_VBD then_RB normalized_VBN by_IN the_DT number_NN of_IN radiolabeled_JJ particles_NNS present_JJ in_IN the_DT medium_NN ._SENT In_IN each_DT experiment_NN ,_, the_DT efficiency_NN of_IN MPsi.gfp_NP packaging_NN by_IN WT_NP Gag_NP was_VBD set_VBN to_TO 100_CD %_NN ._SENT To_TO determine_VB the_DT abilities_NNS of_IN WT_NP and_CC Super_NP M_NP Gag_NP to_TO select_VB for_IN the_DT MPsi-containing_NP mRNA_NN in_IN this_DT assay_NN ,_, the_DT efficiency_NN of_IN MPsi.gfp_NP packaging_NN was_VBD divided_VBN by_IN the_DT efficiency_NN of_IN MPsi(-).gfp_NP packaging_NN ._SENT Hence_RB ,_, this_DT number_NN represents_VBZ the_DT factor_NN of_IN enrichment_NN for_IN Psi-containing_NP mRNA_NP in_IN WT_NP and_CC Super_NP M_NP Gag_NP particles_NNS ._SENT To_TO compare_VB the_DT abilities_NNS of_IN wild-type_NN and_CC Super_NP M_NP Gag_NP to_TO package_VB nonspecific_JJ RNA_NP ,_, QT6_NP cultures_NNS were_VBD cotransfected_VBN with_IN pCMV.MPsi(-).gfp_NN and_CC either_DT pCMV.GagPR_NN or_CC pCMV.Super_NN M.GagPR_NN vectors_NNS ._SENT After_IN 12_CD h_NN ,_, the_DT cells_NNS were_VBD trace_NN labeled_VBN with_IN [_SYM 35S]methionine_JJ and_CC particle-associated_JJ RNA_NP was_VBD purified_VBN as_IN described_VBN above_IN ._SENT Nonspecific_JJ packaging_NN of_IN MPsi(-).gfp_NP mRNA_NP was_VBD quantified_VBN by_IN RPA_NP and_CC normalized_VBD to_TO the_DT amount_NN of_IN radiolabeled_JJ Gag_NP present_NN in_IN the_DT medium_NN ._SENT For_IN comparison_NN ,_, the_DT level_NN of_IN MPsi(-).gfp_NP packaging_NN by_IN the_DT WT_NP was_VBD set_VBN to_TO 100_CD %_NN ._SENT Subcellular_JJ targeting_VBG properties_NNS of_IN Super_NP M._NP |_SYM Construction_NN of_IN the_DT pGag-GFP_JJ expression_NN plasmid_NN was_VBD described_VBN previously_RB ._SENT To_TO create_VB pDeltaNC-GFP_NN ,_, the_DT region_NN between_IN nt_JJ 1044_CD and_CC 1865_CD in_IN gag_NN was_VBD amplified_VBN by_IN PCR_NP ._SENT The_DT primer_NN sequences_NNS were_VBD as_RB follows_VBZ :_: sense_NN ,_, 5'-GGGCAAGGGTCAGGG_NP ;_: antisense_NN ,_, 5'-GTTTGGGGCCCCCTCTCTCTATTGAC_NP ._SENT To_TO prepare_VB the_DT PCR_NP product_NN for_IN cloning_VBG ,_, we_PP made_VBD use_NN of_IN the_DT endogenous_JJ EspI_NP site_NN at_IN nt_NN 1419_CD in_IN gag_NN and_CC the_DT ApaI_NP site_NN engineered_VBN by_IN the_DT antisense_NN PCR_NP primer_NN (_( underlined_VBN )_) ._SENT The_DT digested_VBN fragment_NN was_VBD then_RB exchanged_VBN with_IN the_DT EspI/ApaI_NP fragment_NN of_IN pGag-GFP_NN ._SENT The_DT resulting_VBG sequences_NNS encode_VB a_DT chimera_NN in_IN which_WDT GFP_NP is_VBZ fused_VBN to_TO the_DT C_NP terminus_NN of_IN the_DT seventh_JJ residue_NN of_IN the_DT NC_NP domain_NN in_IN Gag_NP ._SENT Hence_RB ,_, the_DT remaining_VBG C-terminal_JJ residues_NNS of_IN Gag_NP ,_, including_VBG the_DT I_CD domains_NNS and_CC the_DT zinc_NN fingers_NNS ,_, are_VBP absent_JJ in_IN DeltaNC-GFP_NP ._SENT To_TO create_VB pSuperM-GFP_NN and_CC pSuperM-DeltaNC-GFP_NN ,_, the_DT SstI/BspEI_NP fragment_NN encoding_VBG the_DT Super_NP M_NP Gag_NP substitutions_NNS was_VBD exchanged_VBN with_IN the_DT corresponding_JJ WT_NP sequences_NNS in_IN pGag-GFP_NN and_CC pDeltaNC-GFP_NN ,_, respectively_RB ._SENT The_DT subcellular_JJ distributions_NNS of_IN the_DT GFP-tagged_JJ chimeras_NNS in_IN transfected_JJ QT6_NP cells_NNS were_VBD examined_VBN by_IN confocal_JJ microscopy_NN as_IN previously_RB described_VBN ._SENT To_TO determine_VB the_DT effects_NNS of_IN LMB_NP treatment_NN on_IN WT_NP and_CC mutant_JJ Gag-GFP_NP localization_NN ,_, transfected_JJ QT6_NP cells_NNS were_VBD treated_VBN with_IN the_DT drug_NN at_IN a_DT final_JJ concentration_NN of_IN 10_CD ng/ml_NNS for_IN 3_CD h_NN before_IN examination_NN by_IN confocal_JJ microscopy_NN ._SENT In_IN a_DT previous_JJ report_NN ,_, the_DT 11_CD basic_JJ residues_NNS in_IN the_DT RSV_NP Gag_NP M_NP domain_NN were_VBD shown_VBN to_TO be_VB essential_JJ for_IN Gag_NP targeting_VBG to_TO the_DT plasma_NN membrane_NN ._SENT To_TO further_RBR investigate_VB the_DT possibility_NN that_IN Gag_NP binds_VBZ the_DT plasma_NN membrane_NN by_IN forming_VBG electrostatic_JJ interactions_NNS with_IN acidic_JJ phospholipids_NNS ,_, additional_JJ basic_JJ residues_NNS were_VBD introduced_VBN into_IN the_DT M_NP domain_NN ,_, and_CC these_DT changes_NNS were_VBD shown_VBN to_TO enhance_VB budding_VBG from_IN mammalian_JJ (_( COS-1_JJ )_) cells_NNS ._SENT The_DT most_RBS dramatic_JJ increase_NN in_IN budding_VBG was_VBD observed_VBN with_IN a_DT mutant_NN ,_, designated_VBN Super_NP M_NP ,_, whose_WP$ Gag_NN contains_VBZ two_CD substitutions_NNS ,_, E25K_NP and_CC E70K_NP ._SENT These_DT substitutions_NNS simultaneously_RB increased_VBD the_DT number_NN of_IN basic_JJ residues_NNS in_IN the_DT M_NP domain_NN from_IN 11_CD to_TO 13_CD and_CC decreased_VBD the_DT number_NN of_IN acidic_JJ residues_NNS from_IN 6_CD to_TO 4_CD ._SENT Hence_RB ,_, the_DT Super_NP M_NP substitutions_NNS cause_VBP a_DT net_JJ shift_NN of_IN +4_NN in_IN the_DT M_NP domain_NN ._SENT Analysis_NN of_IN Super_NP M_NP virus_NN budding_VBG and_CC infectivity_NN ._SENT |_SYM To_TO further_VB our_PP$ analysis_NN of_IN Super_NP M_NP ,_, the_DT mutant_JJ sequence_NN was_VBD subcloned_VBN into_IN pRS.V8-EGFP_NN ,_, a_DT proviral_JJ plasmid_NN derived_VBN from_IN pRCAS-EGFP_NN ._SENT Metabolic_JJ labeling_VBG of_IN transfected_JJ QT6_NP cells_NNS subsequently_RB showed_VBD that_IN Super_NP M_NP produced_VBD three_CD times_NNS more_JJR virus_NN than_IN the_DT WT_NP control_NN ,_, whereas_IN the_DT level_NN of_IN the_DT previously_RB described_VBN Src_NP chimera_NN ,_, Myr1E_NP ,_, was_VBD enhanced_VBN by_IN about_RB twofold_JJ ._SENT The_DT enhanced_JJ rate_NN of_IN release_NN of_IN these_DT two_CD mutants_NNS was_VBD confirmed_VBN by_IN pulse-chase_NN analyses_NNS ._SENT As_IN shown_VBN in_IN Fig._NN ,_, the_DT pulse-labeled_JJ mutants_NNS disappeared_VBD from_IN the_DT cells_NNS more_RBR quickly_RB than_IN the_DT WT_NP ,_, with_IN the_DT levels_NNS of_IN Super_NP M_NP and_CC Myr1E_NN being_VBG reduced_VBN to_TO less_JJR than_IN one-half_NN of_IN WT_NP levels_NNS after_IN chasing_VBG for_IN 30_CD min_NN ._SENT Concurrent_JJ with_IN their_PP$ increased_VBN rate_NN of_IN disappearance_NN from_IN the_DT cell_NN ,_, Super_NP M_NP and_CC Myr1E_JJ proteins_NNS accumulated_VBN more_RBR rapidly_RB in_IN the_DT media_NNS ._SENT Therefore_RB ,_, Super_NP M_NP and_CC Myr1E_NP bud_VBP much_RB faster_JJR than_IN WT_NP virus_NN ._SENT Interestingly_RB ,_, 50_CD to_TO 60_CD %_NN of_IN the_DT amount_NN of_IN wild-type_NP Gag_NP synthesized_VBD during_IN the_DT pulse_NN was_VBD recovered_VBN in_IN the_DT cell_NN and_CC media_NN fractions_NNS at_IN the_DT end_NN of_IN the_DT chase_JJ (_( 120_CD min_NN )_) ,_, whereas_IN approximately_RB 80_CD %_NN of_IN Super_NP M_NP Gag_NP was_VBD accounted_VBN for_IN ._SENT Given_VBN the_DT correlation_NN between_IN increased_VBN recovery_NN and_CC enhanced_JJ budding_VBG ,_, it_PP was_VBD possible_JJ that_IN rapid_JJ escape_NN from_IN the_DT cytoplasm_NN reduced_VBN Gag_NP loss_NN due_JJ to_TO premature_JJ processing_NN by_IN the_DT viral_JJ PR_NP or_CC degradation_NN by_IN cellular_JJ machinery_NN ._SENT To_TO determine_VB whether_IN PR_NP affected_JJ recovery_NN ,_, PR-_NP versions_NNS of_IN the_DT WT_NP and_CC Super_NP M_NP were_VBD expressed_VBN from_IN gag-only_JJ vectors_NNS and_CC analyzed_VBD as_RB shown_VBN in_IN Fig._NN ._SENT In_IN this_DT case_NN ,_, approximately_RB 90_CD %_NN of_IN the_DT pulse-labeled_JJ WT_NP and_CC Super_NP M_NP proteins_NNS were_VBD recovered_VBN at_IN the_DT final_JJ chase_NN point_NN (_( data_NNS not_RB shown_VBN )_) ._SENT Thus_RB ,_, the_DT difference_NN in_IN recovery_NN between_IN PR+_JJ versions_NNS of_IN the_DT WT_NP and_CC Super_NP M_NP is_VBZ likely_RB due_JJ to_TO differences_NNS in_IN the_DT relative_JJ budding_JJ rates_NNS rather_RB than_IN a_DT gross_JJ change_NN in_IN protein_NN stability_NN ._SENT As_RB mentioned_VBN above_RB ,_, Myr1E_NNS was_VBD previously_RB shown_VBN to_TO be_VB noninfectious_JJ ._SENT Since_IN Super_NP M_NP and_CC Myr1E_JJ exhibit_NN similar_JJ ,_, enhanced_JJ budding_JJ rates_NNS ,_, we_PP considered_VBD the_DT possibility_NN that_IN Super_NP M_NP would_MD be_VB noninfectious_JJ as_RB well_RB ._SENT To_TO test_VB this_DT ,_, WT_NP and_CC mutant_JJ viruses_NNS were_VBD collected_VBN from_IN transfected_JJ QT6_NP cells_NNS ._SENT Media_NNS containing_VBG equal_JJ numbers_NNS of_IN particles_NNS were_VBD then_RB transferred_VBN to_TO primary_JJ cultures_NNS of_IN TEFs_NP ._SENT The_DT kinetics_NNS of_IN virus_NN spreading_VBG were_VBD determined_VBN by_IN examining_VBG the_DT cultures_NNS at_IN days_NNS 3_CD ,_, 7_CD ,_, and_CC 14_CD postinfection_NN ._SENT Infected_JJ cells_NNS were_VBD detected_VBN by_IN fluorescence-activated_JJ cell_NN sorting_VBG (_( FACS_NP )_) because_IN the_DT proviruses_NNS expressed_VBD gfp_NN from_IN the_DT nonessential_NN ,_, v-src_NN region_NN of_IN the_DT genome_NN ._SENT To_TO determine_VB the_DT sensitivity_NN of_IN this_DT method_NN ,_, serial_JJ twofold_JJ dilutions_NNS of_IN infected_JJ (_( GFP-positive_JJ )_) cells_NNS were_VBD made_VBN with_IN uninfected_JJ (_( GFP-negative_JJ )_) cells_NNS ._SENT Subsequent_JJ analyses_NNS revealed_VBD that_IN FACS_NP reliably_RB detected_VBD GFP-positive_JJ cells_NNS in_IN a_DT linear_JJ range_NN from_IN 1_CD to_TO 100_CD %_NN of_IN the_DT total_JJ population_NN examined_VBN (_( 10,000_CD cells_NNS )_) (_( data_NNS not_RB shown_VBN )_) ._SENT Despite_IN the_DT apparent_JJ sensitivity_NN of_IN this_DT assay_NN ,_, fluorescent_JJ cells_NNS were_VBD not_RB detected_VBN in_IN the_DT TEF_NP cultures_NNS incubated_VBN with_IN Super_NP M_NP virus_NN ._SENT Moreover_RB ,_, no_DT infectivity_NN was_VBD detected_VBN when_WRB 104-fold_JJ more_JJR Super_NP M_NP virus_NN (_( relative_JJ to_TO the_DT WT_NP control_NN )_) was_VBD incubated_VBN with_IN the_DT TEF_NP cultures_NNS (_( data_NNS not_RB shown_VBN )_) ._SENT Therefore_RB ,_, Super_NP M_NP is_VBZ noninfectious_JJ ._SENT Physical_JJ properties_NNS and_CC composition_NN of_IN the_DT Super_NP M_NP virus_NN ._SENT |_SYM To_TO uncover_VB the_DT cause(s)_NN of_IN the_DT Super_NP M_NP infectivity_NN defect_NN ,_, several_JJ features_NNS of_IN the_DT mutant_JJ virus_NN were_VBD examined_VBN ._SENT Thin_JJ sections_NNS of_IN Super_JJ M-producing_NN cells_NNS examined_VBN by_IN electron_NN microscopy_NN revealed_VBD particles_NNS of_IN normal_JJ size_NN with_IN electron-dense_NN cores_NNS like_IN those_DT of_IN mature_NP ,_, WT_NP virus_NN ._SENT Analysis_NN of_IN particles_NNS by_IN isopycnic_JJ sucrose_NN gradient_NN centrifugation_NN showed_VBD that_IN the_DT density_NN of_IN Super_NP M_NP virus_NN was_VBD like_JJ that_IN of_IN WT_NP particles_NNS ,_, with_IN the_DT peak_NN of_IN each_DT population_NN banding_VBG at_IN a_DT density_NN of_IN 1.16_CD g/ml_NN in_IN sucrose_NN ._SENT To_TO determine_VB the_DT levels_NNS of_IN Env_NP and_CC Pol_NP incorporation_NN ,_, particles_NNS were_VBD collected_VBN from_IN transfected_JJ QT6_NP cells_NNS and_CC analyzed_VBN by_IN RT_NP assays_NNS using_VBG exogenous_JJ templates_NNS and_CC primers_NNS ._SENT Virus_NN sample_NN volumes_NNS corresponding_JJ to_TO equal_VB amounts_NNS of_IN RT_NP activity_NN were_VBD denatured_VBN ,_, separated_VBN by_IN SDS-PAGE_NP ,_, and_CC probed_VBD by_IN Western_NP blotting_VBG ._SENT With_IN a_DT primary_JJ antibody_NN specific_NN for_IN RSV_NP Gag_NP and_CC Gag-derived_NP proteins_NNS (_( anti-Gag_NP )_) ,_, equal_JJ amounts_NNS of_IN CA_NP (_( 27_CD kDa_NNS )_) were_VBD detected_VBN in_IN the_DT WT_NP and_CC Super_NP M_NP lanes_NNS ._SENT Since_IN these_DT samples_NNS were_VBD first_RB normalized_VBN by_IN RT_NP activity_NN ,_, this_DT result_NN indicates_VBZ that_IN the_DT ratios_NNS of_IN Gag_NP to_TO Pol_NP for_IN WT_NP and_CC Super_NP M_NP viruses_NNS are_VBP similar_JJ ._SENT Likewise_RB ,_, an_DT antibody_NN specific_JJ for_IN the_DT TM_JJ subunit_NN of_IN Env_NP (_( anti-TM_NP )_) yielded_VBD bands_NNS of_IN equal_JJ intensities_NNS when_WRB the_DT WT_NP and_CC Super_NP M_NP samples_NNS were_VBD normalized_VBN by_IN RT_NP activity_NN ._SENT Here_RB ,_, however_RB ,_, the_DT TM_NP bands_NNS migrated_VBD faster_RBR than_IN the_DT published_VBN mobility_NN of_IN 37_CD kDa_NN ,_, a_DT difference_NN probably_RB due_JJ to_TO fewer_JJR glycosylation_NN sites_NNS in_IN the_DT TM_JJ subunit_NN of_IN this_DT particular_JJ strain_NN of_IN RSV_NP ._SENT In_IN contrast_NN to_TO the_DT levels_NNS of_IN Env_NP and_CC Pol_NP ,_, the_DT amounts_NNS of_IN genomic_JJ RNA_NP packaged_VBN by_IN Super_NP M_NP were_VBD significantly_RB reduced_VBN ._SENT This_DT defect_NN was_VBD first_RB identified_VBN by_IN slot_NN blot_NN analyses_NNS using_VBG RNA_NP purified_VBN from_IN equal_JJ numbers_NNS of_IN WT_NP and_CC mutant_JJ particles_NNS ._SENT Specifically_RB ,_, Super_NP M_NP contained_VBD only_RB 10_CD %_NN of_IN the_DT amount_NN of_IN vRNA_NN found_VBN in_IN WT_NP virus_NN ._SENT Northern_JJ blotting_VBG and_CC RPAs_NP confirmed_VBD the_DT severity_NN of_IN this_DT defect_NN (_( data_NNS not_RB shown_VBN )_) ._SENT To_TO determine_VB whether_IN the_DT Super_NP M_NP packaging_NN deficiency_NN was_VBD due_JJ to_TO a_DT paucity_NN of_IN vRNA_NN inside_IN the_DT cell_NN ,_, perhaps_RB as_IN a_DT result_NN of_IN vRNA_NN instability_NN due_JJ to_TO the_DT Super_NP M_NP mutations_NNS ,_, RNA_NP was_VBD also_RB purified_VBN from_IN the_DT transfected_JJ monolayers_NNS ._SENT As_IN shown_VBN in_IN Fig._NN ,_, however_RB ,_, the_DT Super_NP M-expressing_NP cells_NNS contained_VBD normal_JJ amounts_NNS of_IN genomic_JJ RNA_NP ._SENT Therefore_RB ,_, the_DT Super_NP M_NP packaging_NN defect_NN is_VBZ not_RB due_JJ to_TO a_DT gross_JJ reduction_NN in_IN the_DT level_NN of_IN intracellular_JJ vRNA_NN ._SENT Although_IN the_DT mutations_NNS that_WDT cause_VBP the_DT two_CD acidic-to-basic_JJ substitutions_NNS in_IN Super_NP M_NP lie_VBP downstream_RB of_IN the_DT packaging_NN signal_NN ,_, it_PP was_VBD possible_JJ that_IN these_DT mutations_NNS somehow_RB altered_VBD folding_VBG in_IN the_DT 5_CD '_POS end_NN of_IN the_DT vRNA_NN and_CC disrupted_VBN stem-loop_NN structures_NNS that_WDT are_VBP critical_JJ for_IN Psi_NP function_NN ._SENT Alternatively_RB ,_, the_DT Super_NP M_NP changes_NNS might_MD have_VB altered_VBN folding_VBG in_IN the_DT NC_NP domain_NN and_CC prevented_VBD Gag_NP from_IN recognizing_VBG the_DT Psi_NP sequence_NN ._SENT To_TO test_VB these_DT possibilities_NNS ,_, a_DT plasmid_NN expressing_VBG MPsi.gfp_NP ,_, an_DT RNA_NP consisting_VBG of_IN the_DT 160-nt_JJ RSV_NP minimal_JJ packaging_NN sequence_NN ,_, MPsi_NP ,_, at_IN the_DT 5_CD '_POS end_NN of_IN a_DT nonviral_JJ (_( gfp_NN )_) mRNA_NN ,_, was_VBD generated_VBN ._SENT With_IN this_DT vector_NN ,_, designated_VBN pCMV.MPsi.gfp_NN ,_, the_DT abilities_NNS of_IN WT_NP and_CC mutant_JJ Gag_NP proteins_NNS (_( expressed_VBN from_IN pCMV.GagPR_NN ,_, a_DT gag-only_JJ expression_NN vector_NN )_) to_TO package_VB identical_JJ ,_, MPsi-containing_NP mRNA_NP were_VBD compared_VBN ._SENT To_TO determine_VB the_DT specificity_NN of_IN packaging_NN in_IN this_DT system_NN ,_, the_DT pCMV.MPsi.gfp_NN plasmid_NN was_VBD cotransfected_VBN with_IN pCMV.MPsi(-).gfp_NN ,_, a_DT vector_NN that_WDT expresses_VBZ a_DT gfp_NN mRNA_NN lacking_VBG the_DT MPsi_NP sequence_NN ._SENT Under_IN these_DT conditions_NNS ,_, Super_NP M_NP Gag_NP packaged_VBN about_IN one-fourth_NN the_DT amount_NN of_IN MPsi.gfp_NP found_VBD in_IN WT_NP virus-like_JJ particles_NNS (_( VLPs_NP )_) ._SENT Thus_RB ,_, the_DT genome_NN packaging_NN defect_NN seen_VBN in_IN provirus-transfected_JJ cells_NNS is_VBZ likely_RB due_JJ to_TO the_DT amino_NN acid_NN substitutions_NNS in_IN the_DT Super_NP M_NP protein_NN rather_RB than_IN to_TO the_DT mutations_NNS made_VBN in_IN the_DT genomic_JJ RNA_NP ._SENT With_IN MPsi.gfp_NP ,_, however_RB ,_, the_DT Super_NP M_NP defect_NN was_VBD less_RBR pronounced_VBN (_( i.e._FW ,_, genome_NN packaging_NN was_VBD 1/10_CD WT_NP levels_NNS ,_, whereas_IN MPsi.gfp_NP packaging_NN was_VBD 1/4_CD WT_NP levels_NNS )_) ._SENT A_DT possible_JJ explanation_NN for_IN this_DT difference_NN is_VBZ that_IN the_DT number_NN of_IN MPsi.gfp_NP mRNAs_NNS (_( produced_VBN by_IN the_DT cytomegalovirus_NN immediate-early_JJ promoter_NN )_) may_MD have_VB exceeded_VBN the_DT number_NN of_IN viral_JJ genomes_NNS that_IN Gag_NP normally_RB encounters_VBZ in_IN an_DT infected_JJ cell_NN ._SENT Nevertheless_RB ,_, packaging_NN of_IN MPsi.gfp_NP mRNA_NP by_IN WT_NP and_CC Super_NP M_NP Gag_NP was_VBD apparently_RB specific_JJ because_IN incorporation_NN of_IN the_DT MPsi-_NP control_NN was_VBD only_RB 1/5_CD to_TO 1/10_CD as_IN efficient_JJ ._SENT This_DT result_NN reveals_VBZ that_IN ,_, although_IN the_DT absolute_JJ amounts_NNS differed_VBD ,_, the_DT ratios_NNS of_IN MPsi_NP to_TO MPsi(-).gfp_NP mRNA_NP in_IN WT_NP and_CC Super_NP M_NP VLPs_NP were_VBD similar_JJ ._SENT Thus_RB ,_, the_DT ability_NN to_TO select_VB for_IN MPsi-containing_NP RNA_NP suggests_VBZ that_IN the_DT Super_NP M_NP substitutions_NNS do_VBP not_RB weaken_VB NC_NP 's_POS specificity_NN for_IN vRNA_NN ._SENT Instead_RB ,_, the_DT Super_NP M_NP domain_NN may_MD prevent_VB packaging_NN by_IN an_DT indirect_JJ mechanism_NN ,_, perhaps_RB by_IN enabling_VBG Gag_NP to_TO leave_VB the_DT site_NN of_IN genome_NN packaging_NN more_RBR quickly_RB ._SENT Given_VBN recent_JJ data_NNS suggesting_VBG that_IN RNA_NP is_VBZ required_VBN to_TO serve_VB a_DT structural_JJ role_NN during_IN retrovirus_NN assembly_NN ,_, the_DT ability_NN of_IN Super_NP M_NP to_TO incorporate_VB nonspecific_JJ ,_, cellular_JJ RNA_NP was_VBD investigated_VBN ._SENT In_IN this_DT case_NN ,_, either_CC WT_NP or_CC Super_NP M_NP gag-only_NP (_( pCMV.GagPR_NN )_) expression_NN vectors_NNS were_VBD cotransfected_VBN into_IN QT6_NP cells_NNS with_IN pCMV.MPsi(-).gfp_NN ,_, which_WDT makes_VBZ mRNA_NN that_WDT can_MD only_RB be_VB packaged_VBN nonspecifically_RB ._SENT The_DT amounts_NNS of_IN MPsi(-).gfp_NP mRNA_NP in_IN the_DT cell_NN and_CC medium_NN fractions_NNS were_VBD determined_VBN by_IN RPA_NP ,_, and_CC the_DT packaging_NN efficiency_NN was_VBD calculated_VBN by_IN normalizing_VBG to_TO the_DT amount_NN of_IN Gag_NP released_VBD ._SENT Under_IN these_DT conditions_NNS ,_, Super_NP M_NP Gag_NP packaged_VBD about_RB one-half_JJ the_DT amount_NN of_IN MPsi(-).gfp_NP mRNA_NP found_VBD in_IN WT_NP VLPs_NP ._SENT Hence_RB ,_, this_DT result_NN suggests_VBZ that_IN Super_NP M_NP is_VBZ able_JJ to_TO "_`` compensate_VB "_'' for_IN the_DT vRNA_NN packaging_NN defect_NN by_IN incorporating_VBG nonspecific_JJ ,_, cellular_JJ RNA_NP ._SENT However_RB ,_, because_IN Super_NP M_NP Gag_NP exhibited_VBD a_DT twofold_JJ reduction_NN in_IN the_DT relative_JJ level_NN of_IN MPsi(-).gfp_NP incorporation_NN ,_, it_PP seems_VBZ likely_RB that_IN the_DT rapid_JJ rate_NN of_IN budding_JJ inhibits_VBZ nonspecific_JJ RNA_NP packaging_NN ,_, albeit_IN to_TO a_DT much_RB lesser_JJR degree_NN than_IN vRNA_NN packaging_NN ._SENT Despite_IN the_DT reduced_VBN amount_NN of_IN RNA_NP incorporation_NN ,_, Super_NP M_NP virus_NN appeared_VBD normal_JJ by_IN electron_NN microscopy_NN and_CC exhibited_VBN WT_NP density_NN in_IN sucrose_NN ._SENT Therefore_RB ,_, the_DT level_NN of_IN total_JJ 